IndraLab
Statements
SCN8A inhibits lipopolysaccharide. 5 / 5
|
5
reach
"MED inhibited LPS induced nuclear translocation of nuclear factor (NF)-kappaB (NF-kappaB) p65, IkappaB degradation, IkappaB kinase (IKK) phosphorylation, and the activation of extracellular signal regulated kinase (ERK), c-jun N-terminal kinase (JNK), and p38, suggesting that MED blocks the activation of both NF-kappaB and mitogen activated protein kinase (MAPK) pathways."
reach
"MED significantly inhibited LPS induced production of pro inflammatory mediators such as tumor necrosis factor alpha (TNF-alpha), interleukin-1beta (IL-1beta), interleukin-6 (IL-6), interferon-gamma (INF-gamma), and nitric oxide (NO), whereas it increased anti-inflammatory interleukin-10 (IL-10) and transforming growth factor-beta1 (TGF-beta1) production in BV2 microglia in a concentration dependent manner without causing cytotoxicity."